Key Financial Data Of Reporting Company

BrightPath Biotherapeutics Co., Ltd. - Filing #7580403

Concept As at
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
As at
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
As at
2019-03-31
As at
2018-03-31
As at
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2016-04-01 to
2017-03-31
As at
2017-03-31
As at
2017-03-31
2016-04-01 to
2017-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
2,504,000 JPY
JPY
11,300,000 JPY
JPY
155,808,000 JPY
JPY
354,410,000 JPY
354,410,000 JPY
529,612,000 JPY
529,612,000 JPY
Ordinary profit (loss)
-1,738,636,000 JPY
JPY
-1,823,996,000 JPY
JPY
-1,678,084,000 JPY
JPY
-1,569,648,000 JPY
-1,573,292,000 JPY
-1,089,724,000 JPY
-1,116,556,000 JPY
Profit (loss)
-1,719,634,000 JPY
-1,857,774,000 JPY
-1,884,318,000 JPY
-1,577,142,000 JPY
-1,113,661,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
JPY
JPY
Share capital
6,459,712,000 JPY
5,433,211,000 JPY
5,427,836,000 JPY
5,419,931,000 JPY
3,774,413,000 JPY
Total number of issued shares
50,817,500 xbrli:shares
42,101,000 xbrli:shares
41,993,500 xbrli:shares
41,835,400 xbrli:shares
37,218,400 xbrli:shares
Net assets
JPY
3,537,642,000 JPY
JPY
3,235,237,000 JPY
JPY
5,096,072,000 JPY
6,950,570,000 JPY
6,950,570,000 JPY
5,201,149,000 JPY
5,199,874,000 JPY
Total assets
JPY
3,749,428,000 JPY
JPY
3,474,639,000 JPY
JPY
5,304,463,000 JPY
7,237,434,000 JPY
7,235,902,000 JPY
5,408,300,000 JPY
5,404,266,000 JPY
Net assets per share
69.10
75.49
119.66
164.78
164.78
139.17
139.17
Dividend paid per share
Interim dividend paid per share
Basic earnings (loss) per share
-36.14
-44.20
-44.95
-41.25
-41.25
-32.74
-32.74
Diluted earnings per share
Equity-to-asset ratio
xbrli:pure
0.937 xbrli:pure
xbrli:pure
0.915 xbrli:pure
xbrli:pure
0.947 xbrli:pure
0.952 xbrli:pure
0.953 xbrli:pure
0.958 xbrli:pure
0.958 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-1,769,848,000 JPY
JPY
-1,784,461,000 JPY
JPY
-1,457,571,000 JPY
JPY
JPY
-1,591,336,000 JPY
JPY
-1,067,512,000 JPY
Net cash provided by (used in) investing activities
-36,211,000 JPY
JPY
-106,879,000 JPY
JPY
-185,115,000 JPY
JPY
JPY
-111,556,000 JPY
JPY
-96,564,000 JPY
Net cash provided by (used in) financing activities
2,053,090,000 JPY
JPY
8,521,000 JPY
JPY
15,810,000 JPY
JPY
JPY
3,281,082,000 JPY
JPY
3,559,188,000 JPY
Cash and cash equivalents
JPY
3,265,388,000 JPY
JPY
3,018,356,000 JPY
JPY
4,901,177,000 JPY
JPY
6,528,759,000 JPY
4,950,570,000 JPY
JPY
Number of employees
xbrli:pure
7 xbrli:pure
44 xbrli:pure
xbrli:pure
44 xbrli:pure
xbrli:pure
42 xbrli:pure
42 xbrli:pure
42 xbrli:pure
37 xbrli:pure
37 xbrli:pure
Average number of temporary employees
xbrli:pure
4 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
3 xbrli:pure
4 xbrli:pure
4 xbrli:pure
4 xbrli:pure
4 xbrli:pure
Total shareholder return
0.226 xbrli:pure
0.252 xbrli:pure
0.358 xbrli:pure
0.935 xbrli:pure
0.729 xbrli:pure
Total return on share price index
1.179 xbrli:pure
0.607 xbrli:pure
0.936 xbrli:pure
1.182 xbrli:pure
1.049 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.